Bioinformatics sits at the exciting intersection where biology meets data science, using powerful computer tools to decode the vast complexity of living systems. From mapping the human genome to tracking how viruses evolve, this field transforms raw biological information into actionable insights that drive modern medicine and research forward without requiring a supercomputer to understand the basics.

On Gist.Science, we ensure you never miss a breakthrough by processing every new preprint in this category directly from bioRxiv. Our team provides both plain-language explanations and detailed technical summaries for each paper, making cutting-edge discoveries accessible to everyone regardless of their background.

Below are the latest bioinformatics papers added from bioRxiv, ready for you to explore with clarity and depth.

💻 bioinformatics

A Context-Specific, Literature-Supported Framework for Validating Stress Response Differentially Expressed Gene Sets

This paper presents a context-specific framework that validates stress-response gene sets by leveraging protein-protein interaction networks restricted to differentially expressed genes, demonstrating that biologically supported "Principal Response" genes form significantly interconnected subnetworks across temperature conditions.

Frishman, B. A., Gonzalez, J. L., Forbes, V. E.2026-05-13
💻 bioinformatics

An improved generic schema for high fidelity data linkage and sample tracing across complex multi-assay medical entomology studies

This paper demonstrates that an improved generic data schema successfully ensures high-fidelity linkage and robust sample traceability across complex, multi-team, multi-stage malaria vector studies in Tanzania, achieving near-perfect data integration from field collection through insectary rearing and laboratory analysis.

Kavishe, D. R., Msoffe, R. V., Mmbaga, S., Tarimo, L. J., Butler, F., Kaindoa, E. W., Govella, N. J., Kiware, S. S., Kil (…)2026-05-13
💻 bioinformatics

CardioSafe: Multi-task prediction of cardiac ion channel activity with reverse-leak audited benchmarking

CardioSafe is a multi-task neural network that integrates chemical and transcriptomic features to predict cardiac ion channel activity, demonstrating superior performance over existing methods once a reverse-leak audit revealed and removed training-data contamination that had previously inflated benchmark results for Nav1.5 and Cav1.2 channels.

Jovanovic, M., Weidener, L. S., Brkic, M., Ulgac, E., Meduri, A.2026-05-12
💻 bioinformatics

CausalKnowledgeTrace: A Novel Computational Framework for Automated Literature-Based Causal Graph Construction and Evidence-Based Variable Selection in Biomedical Research

CausalKnowledgeTrace is a scalable, Python-based computational framework that automates the construction of evidence-based causal graphs from biomedical literature to systematically identify confounders and bias structures for improved causal inference in observational studies.

Upadhayaya, R., Pradhan, M. M., Metzger, V. T., Malec, S. A.2026-05-12
💻 bioinformatics

The elusive resistome: a global comparison reveals large discrepancies among detection pipelines

This study demonstrates that the lack of standardized methodology in antibiotic resistance gene detection leads to massive discrepancies among pipelines, causing the same metagenomic data to yield conflicting biological interpretations and underscoring the need for researchers to carefully justify and communicate their chosen analytical approaches.

Inda-Diaz, J. S., Adegoke, F., Löber, U., Jarquin-Diaz, V. H., Duan, Y., Bengtsson-Palme, J., Ugarcina Perovic, S., Coe (…)2026-05-12
💻 bioinformatics

Zero-shot biological reasoning with open-weights large language models reproduces CRISPR screen based prediction of synthetic lethal interactions.

This study demonstrates that open-weight large language models, particularly Qwen2.5-32B-Instruct, can effectively predict synthetic lethal interactions by leveraging pre-trained biological knowledge to outperform random chance and non-LLM methods, offering a scalable and interpretable alternative for prioritizing novel therapeutic targets in cancer.

Prosz, A. G., Sztupinszki, Z., Diossy, M., Kilim, O., Zimon, B., Szallasi, Z., Csabai, I. G.2026-05-11